JP Morgan analyst Anupam Rama issued a note on Thursday maintaining a positive outlook on Kiniksa Pharmaceuticals International (NASDAQ:KNSA), citing Arcalyst’s strong commercial performance and the company's focused pipeline.
JP Morgan maintains the Overweight rating with a price…